Skip to search formSkip to main contentSkip to account menu

prasugrel hydrochloride

Known as: Hydrochloride, Prasugrel, Prasugrel HCl, Prasugrel Hydrochloride [Chemical/Ingredient] 
A piperazine derivative and PLATELET AGGREGATION INHIBITOR that is used to prevent THROMBOSIS in patients with ACUTE CORONARY SYNDROME; UNSTABLE… 
National Institutes of Health

Related topics

Related topics

14 relations

Narrower (4)

CS 747EffientEfientLY 640315
In Bloodagonistsanalogs & derivativesantagonists & inhibitors

Broader (1)

Platelet Aggregation Inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Acquired Factor V Inhibitor with Hemorrhagic Symptoms after Prasugrel Hydrochloride Treatment
Acquired factor V inhibitor (AFVI) is a rare coagulopathy. It may be triggered by specific antigens such as antibiotics. We… 
2017
2017
Absence of differential effect of ticagrelor versus prasugrel maintenance dose on endothelial function in patients with stable coronary artery disease.
2013
2013
Antiplatelet efficacy of prasugrel in patients with high on-clopidogrel treatment platelet reactivity and a history of coronary stenting
Summary Little is known about the antiplatelet action of the 3rd generation thienopyridine prasugrel in patients showing high… 
2013
2013
Evolving pattern of on-prasugrel and on-ticagrelor platelet reactivity over time in ST elevation myocardial infarction patients.
2012
2012
IDENTIFICATION OF PRASUGREL (AN ANTIPLATELET DRUG) IMPURITIES BY LC-MS/MS, RAPID DETERMINATION OF PRASUGREL HYDROCHLORIDE-RELATED SUBSTANCES, AND DEGRADATION PRODUCTS IN ACTIVE PHARMACEUTICAL…
A simple, sensitive, and reproducible gradient reverse-phase ultra-performance liquid chromatographic (UPLC) method was developed… 
2011
2011
Direct formation of thienopyridine-derived nitrosothiols--just add nitrite!
2011
2011
Relative bioavailability of prasugrel free base in comparison to prasugrel hydrochloride in the presence and in the absence of a proton pump inhibitor
Abstract Prasugrel (CAS 150322-43-3), an inhibitor of platelet activation and aggregation, is indicated to reduce the rate of… 
2011
2011
Direct Vasoactive Properties of Thienopyridine-Derived Nitrosothiols
Abstract Thienopyridines (ticlopidine, clopidogrel, and prasugrel) require in vivo metabolism to exhibit a critical thiol group… 
2010
2010
Kommentar zu den Leitlinien 2010 zur kardiopulmonalen Reanimation des European Resuscitation Council
ZusammenfassungErwachseneThoraxkompressionen (mindestens 100/min, mindestens 5-cm-Drucktiefe): Beatmung (Atemzugvolumen 500–600… 
2008
2008
Excess rates of nonfatal myocardial infarction in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel (preventing clinical events or chasing…
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)